View on web
THE TOP NEWS IN MARIJUANA LAW REFORM
Volume 27 • Issue 47 • December 05, 2024
"This novel transdermal medical cannabis formulation demonstrated significant therapeutic efficacy in ameliorating painful diabetic peripheral neuropathy symptoms," investigators concluded.
Patients' mean pain levels fell from 6.16 prior to cannabis treatment to 3.89 following treatment.
Join the Marijuana Movement This Giving Tuesday 12/3/24
What Rescheduling Might Mean for the District of Columbia 12/2/24
Spark up the Cannabis Conversation at Your Holiday Table 11/28/24
Nebraska: District Judge Upholds Voter-Approved Medical Cannabis Access Initiatives 11/27/24
Inspector General: DEA Agents Prohibited From Randomly Searching Travelers at Airports, Other Transportation Facilities 11/26/24
TAKE ACTION: Tell the White House to Expand Marijuana Pardons and Clemency
Among those ages 65 and older, more than 14 percent reported consuming CBD products.
The Attorney General has filed similar lawsuits against other cities, but has yet to prevail in court.
NORML COMMENTARY: Marijuana prohibitionists are out of step with public opinion
LEARN: Cannabis use is not associated with age-related cognitive decline
FEDERAL: Lawmakers urge Biden to take further actions on cannabis before leaving office